This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thep Himathongkam, MD; Puangpen Dasanabhairochana, MD; Ninlawan Pitchayayothin, BSc; Arporn Sriphrapradang, BSc

JAMA. 1978;239(5):430-431.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CORTICOSTEROIDS have been used topically since 1952 with minimal side effects compared with corticosteroids administered systemically. However, substantial amounts of topically applied corticosteroids may be absorbed percutaneously and cause adrenal suppression.¹ It is surprising that few cases of Cushing's syndrome induced by use of topical steroids have been reported, and those were in children. Cushing's syndrome and hirsutism induced by topically applied desoximetasone (Topicorte) was diagnosed in a woman.

Report of a Cas

A 45-year-old woman was referred to Ramathibodi Hospital for examination for Cushing's syndrome. Two years before admission, hair growth had developed on her face and back to an extent that she had to shave every other day. One year before admission, she experienced reddish striae on her skin and bruising with slight contact. Her weight had increased by 10 kg during the past nine months. She had had psoriasis since age 17 years, and the lesions . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Medicine, Faculty of Medicine, Ramathibodi Hospital and Ramathibodi Research Center, Mahidol University, Bangkok, Thailand.

Footnotes
Reprint requests to Department of Medicine, Ramathibodi Hospital, Rama VI Rd, Bangkok 4, Thailand (Dr Himathongkam).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?